Elicio Therapeutics, Inc. (ELTX)
8.32
+0.71
(+9.33%)
USD |
NASDAQ |
Feb 06, 16:00
8.32
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics EPS Diluted (Quarterly) : -0.604 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.08M |
| Total Expenses (Quarterly) | 10.08M |
| Enterprise Value | 125.78M |
| Earnings Yield | -40.83% |
| Normalized Earnings Yield | -38.67 |